Delayed Nasdaq Stockholm 03:00:02 2024-04-16 am EDT 5-day change 1st Jan Change
179 SEK -1.38% Intraday chart for Stille AB -4.79% +18.54%
Sales 2023 295M 27.01M Sales 2024 * 520M 47.63M Capitalization 1.63B 149M
Net income 2023 * - Net income 2024 * - EV / Sales 2023 2.57 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 3.14 x
P/E ratio 2023 *
-
P/E ratio 2024 *
-
Employees 106
Yield 2023 *
-
Yield 2024 *
-
Free-Float 95.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.38%
1 week-4.79%
Current month-0.56%
1 month+7.19%
3 months+21.36%
6 months+79.72%
Current year+18.54%
More quotes
1 week
179.00
Extreme 179
191.00
1 month
160.00
Extreme 160
191.00
Current year
142.50
Extreme 142.5
191.00
1 year
94.20
Extreme 94.2
191.00
3 years
94.20
Extreme 94.2
191.00
5 years
70.00
Extreme 70
191.00
10 years
8.45
Extreme 8.45
191.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 23-03-19
Director of Finance/CFO 50 20-05-31
Sales & Marketing - -
Members of the board TitleAgeSince
Director/Board Member 64 99-12-31
Director/Board Member 61 20-12-31
Chairman 52 19-12-31
More insiders
Date Price Change Volume
24-04-16 179 -1.38% 233
24-04-15 181.5 -2.94% 9,670
24-04-12 187 +0.27% 6,748
24-04-11 186.5 -0.53% 3,023
24-04-10 187.5 -0.27% 6,874

Delayed Quote Nasdaq Stockholm, April 16, 2024 at 03:00 am EDT

More quotes
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Calendar
More about the company

Quarterly revenue - Rate of surprise